Aug 21 (Reuters) – Pfizer Inc is in advanced talks
to acquire U.S. cancer drug company Medivation Inc for
close to $14 billion, as it seeks to boost its oncology
portfolio, people familiar with the…
The post UPDATE 1-Pfizer nears deal to acquire Medivation for close to $14 bln -sources appeared first on NASDAQ.